A Randomized, Open-label, Oral Single Dosing, Two-way Crossover Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-397 After a Single Oral Dose in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 11 Aug 2017
At a glance
- Drugs Tadalafil/tamsulosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
- 08 Aug 2017 Status changed from active, no longer recruiting to completed.
- 21 Jul 2016 Status changed from not yet recruiting to active, no longer recruiting.
- 01 Dec 2015 New trial record